Make an Appointment
-
Division of Hematology & Oncology460 W 10th Ave, Columbus, OH 43210 map
A hematologist in Columbus, Dr. Yvonne Efebera offers care for blood disorders, including common conditions like anemia or those that are more rare, such as leukemia.
Division of Hematology & Oncology
Accepting New Patients?
Yes, Dr. Yvonne A. Efebera is accepting new patients at this office.
Phone
Address
460 W 10th Ave, Columbus, OH 43210
Office Details
Insurance Accepted
- Medicare
Bio
Dr. Yvonne Efebera graduated from Pennsylvania State University College of Medicine in 1998.
Dr. Efebera has one office in Ohio where she specializes in Hematology and Hematology / Oncology.
Dr. Efebera works with sixteen doctors including Dr. John Byrd and Dr. Steven Devine.
Specialties
-
Hematology
As a hematologist practicing in Columbus, Dr. Efebera is capable of diagnosing and treating patients suffering from all types of blood and blood-borne disorders. These may include conditions such as bleeding & clotting disorders, hematologic malignancies, enlarged lymph nodes or anemia. Dr. Efebera may also craft specialized treatment plans and educate patients on their specific condition(s).
-
Hematology / Oncology
As a hematologist / oncologist in Ohio, Dr. Efebera is capable of diagnosing and treating patients with blood-related disorders, malignancies, or cancers. Dr. Efebera may treat a range of conditions ranging from the the common to the very rare and complex. As a result, Dr. Efebera may provide care as part of a multidisciplinary team, working in conjunction with other specialists to ensure the highest possible standard of care.
Education & Training
Hospital Affiliations
- Arthur G James Cancer Hospital and Research Institute
- Ohio State University Hospitals
Languages Spoken
- English
Links & Social Media
Latest Hematology News
-
HIV Strikes Black Gay Men More, Despite Safer BehaviorsRobert Preidt, Dec 6, 2018 at 2:00 PM
-
An App, Your Fingernail -- and Anemia Screening Is DoneRobert Preidt, Dec 5, 2018 at 12:00 PM
-
Gene Therapy for Sickle Cell Takes Another Step ForwardAmy Norton, HealthDay Reporter, Dec 4, 2018 at 2:00 PM